Zinger Key Points
- Pablo Zuanic, senior analyst at Zuanic & Associates kept a ‘Neutral’ rating on Tilray stock.
- After missing the third quarter earnings, beating the consensus estimates in the fourth quarter is “encouraging,” according to the analyst.
- The analyst predicts Germany and US drinks business as the two main drivers of growth in fiscal year 2025 for Tilray.
- Learn the top momentum trading strategies for today’s whipsaw market, live with Chris Capre on Sunday, May 4 at 1 PM ET. Reserve your free spot now.
Canadian cannabis giant Tilray Brands TLRY reported its financial results Monday for the fourth quarter revealing revenue of $229.882 million, up by 25% year-over-year.
The company's results came in above the consensus estimate of $227.07 million, according to data from Benzinga Pro. Net loss narrowed to $15.4 million in the fourth quarter compared to net loss of $119.8 million in the prior-year quarter. For the full fiscal year 2023, Tilray disclosed a net loss of $222.4 million, compared to a net loss of $1.4 billion.
Pablo Zuanic, senior analyst at Zuanic & Associates kept a ‘Neutral' rating on Tilray stock.
“We believe TLRY should be a long-term holding in any global portfolio of cannabis stocks," Zuanic wrote in a Monday analyst note.
After missing the third quarter earnings, beating the consensus estimates in the fourth quarter is "encouraging," according to the analyst.
Zuanic further suggested that even though there are cheaper cannabis stocks, Tilray's liquidity, large market cap and notable cash balance, plus assets, make it a "more credible" long-term investment.
"In our view, the main two drivers of growth in fiscal year 2025 should be Germany (in particular, and Europe in general) and the US drinks business,” Zuanic said. “A lot remains to be seen, but we are encouraged by Tilray saying its sales in Germany have grown 65% since 4/1."
Read Also: Tilray Can Sell And Distribute Medical Marijuana To German Pharmacies, Hospitals And More
Zuanic said he prefers to stay ‘Neutral' until there is a better line of sight on several metrics.
TLRY Price Action: Tilray shares traded 8.74% higher at $1.99 per share during Tuesday's pre-market session.
Read Next:
Learn all about the future of the cannabis industry at the Benzinga Cannabis Capital Conference this October in Chicago. Hear directly from key industry players and policymakers. Get your tickets now by following this link.
Photo: Courtesy of Bigc Studio via Shutterstock
Edge Rankings
Price Trend
© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Cannabis is evolving—don’t get left behind!
Curious about what’s next for the industry and how to stay ahead in today’s competitive market?
Join top executives, investors, and industry leaders at the Benzinga Cannabis Capital Conference in Chicago on June 9-10. Dive deep into market-shaping strategies, investment trends, and brand-building insights that will define the future of cannabis.
Secure your spot now before prices go up—this is where the biggest deals and connections happen!
